Five-year review of HIV-Hepatitis B virus (HBV) co-infected patients in a New York City AIDS center

Journal of Korean Medical Science

Volumn 27, Issue 7, 2012, Pages 830-833

  Kim, Jong Hun ^a   Psevdos, George ^b,c   Sharp, Victoria ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Affiliate of Columbia University College of Physicians and Surgeons ^*  (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Hepatitis B virus; HIV; Mortality

Indexed keywords

ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE; HEPATITIS B(E) ANTIGEN; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

ADULT; ARTICLE; BLOOD; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; RETROSPECTIVE STUDY; UNITED STATES;

ADENINE; ADULT; ANTI-HIV AGENTS; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEW YORK CITY; ORGANOPHOSPHONATES; RETROSPECTIVE STUDIES;

EID: 84866496866     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.7.830     Document Type: Article

References (18)

1. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44: S6-9.
2. Thio CL. Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 2003; 23: 125-36.
3. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munñoz A, Thomas DL; Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360: 1921-6.
4. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, Benhamou JP, Erlinger S, Valla D, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999; 29: 1306-10.
5. Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006; 44: S65-70.
6. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125: 444-51.
7. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011; 26: 123-30.
8. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
9. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1- infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50: 1387-96.
10. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, Kalapothaki V, Hatzakis A. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis 2009; 48: 1763-71.
11. Hoffmann CJ, Seaberg EC, Young S, Witt MD, D'Acunto K, Phair J, Thio CL. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009; 23: 1881-9.
12. Boyd A, Lasnier E, Molina JM, Lascoux-Combe C, Bonnard P, Miailhes P, Wendum D, Meynard JL, Girard PM, Lacombe K. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. Antivir Ther 2010; 15: 963-74.
13. de Vries-Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, Pas SD, Schutten M, Hoepelman AI, Richter C, Mulder JW, et al. Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology 2010; 139: 1934-41.
14. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol 2005; 34: 132-7.
15. Baumert TF, Thimme R, von Weizsäcker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007; 13: 82-90.
16. Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102-10.
17. Jain MK. Mortality in patients coinfected with hepatitis B virus and HIV: could antiretroviral therapy make a difference? Clin Infect Dis 2009; 48: 1772-4.
18. Tuma P, Jarrin I, Del Amo J, Vispo E, Medrano J, Martin-Carbonero L, Labarga P, Barreiro P, Soriano V. Survival of HIV-infected patients with compensated liver cirrhosis. AIDS 2010; 24: 745-53.